homocysteine has been researched along with enalapril in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Huo, Y; Li, JP; Liu, P | 1 |
| Ge, JB; Guan, DM; Hu, J; Huo, Y; Li, JP; Wang, SY; Wang, YN; Zhang, FM; Zhao, F | 1 |
| Fu, J; Mao, GY; Qin, XH; Tang, GF; Tang, HQ | 1 |
| Fan, FF; Huo, Y; Li, JP; Wang, BY; Wang, X; Xu, X; Xu, XP | 1 |
| Cui, Y; Ge, J; Guan, D; Hu, J; Huo, Y; Li, J; Liu, Z; Qin, X; Wang, X; Wang, Y; Xu, X; Zhang, F; Zhao, Z | 1 |
| Hou, FF; Huo, Y; Li, Y; Liang, M; Qin, X; Sun, D; Wang, B; Wang, J; Xu, X | 1 |
| Cheng, X; Hou, FF; Huo, Y; Li, J; Li, N; Li, Y; Liang, M; Nie, J; Qin, X; Sun, N; Sun, Y; Wang, B; Wang, H; Wang, J; Wang, X; Xu, X; Zhang, Y; Zhao, L | 1 |
| Cai, Y; Cheng, X; Fu, J; He, M; Hou, FF; Huang, X; Huo, Y; Li, J; Qin, X; Sun, N; Tang, G; Wang, B; Wang, X; Zhao, M | 1 |
| Bao, H; Chen, Y; Cheng, X; Cui, Y; He, M; Hou, FF; Huang, X; Huang, Y; Huo, Y; Li, J; Li, P; Li, Y; Qin, X; Sun, N; Tang, G; Wang, B; Wang, J; Yin, D; Zhang, Y | 1 |
| Lu, F; Wei, CY; Yu, XL; Zhang, ZM; Zhao, LY; Zou, Q | 1 |
| Guo, H; Hou, FF; Huo, Y; Li, J; Lin, T; Liu, C; Liu, L; Qin, X; Song, Y; Wang, B; Wang, C; Wang, X; Xu, X; Yu, Y; Zhang, H; Zhang, Y; Zhou, Z | 1 |
| Brown, CJ; Elias, MF | 1 |
10 trial(s) available for homocysteine and enalapril
| Article | Year |
|---|---|
[Efficacy and safety of Enalapril-Folate acid tablets in lowering blood pressure and plasma homocysteine].
Topics: Blood Pressure; Double-Blind Method; Enalapril; Female; Folic Acid; Homocysteine; Humans; Hypertension; Male; Middle Aged; Tablets | 2007 |
[The effect of baseline homocysteine level on the efficacy of enalapril maleate and folic acid tablet in lowering blood pressure and plasma homocysteine].
Topics: Adolescent; Adult; Aged; Double-Blind Method; Enalapril; Female; Folic Acid; Homocysteine; Humans; Hypertension; Male; Middle Aged | 2008 |
[Efficacy of enalapril combined with folic acid in lowering blood pressure and plasma homocysteine level].
Topics: Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Enalapril; Female; Folic Acid; Homocysteine; Humans; Hypotension; Male; Middle Aged; Treatment Outcome | 2009 |
Effect of enalapril on plasma homocysteine levels in patients with essential hypertension.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Enalapril; Female; Genotype; Homocysteine; Humans; Hypertension; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Regression Analysis | 2010 |
MTHFR C677T and MTR A2756G polymorphisms and the homocysteine lowering efficacy of different doses of folic acid in hypertensive Chinese adults.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Aged; Antihypertensive Agents; China; Double-Blind Method; Enalapril; Female; Folic Acid; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Hypertension; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic | 2012 |
Efficacy of Folic Acid Therapy on the Progression of Chronic Kidney Disease: The Renal Substudy of the China Stroke Primary Prevention Trial.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; China; Disease Progression; Double-Blind Method; Drug Combinations; Enalapril; Female; Folic Acid; Glomerular Filtration Rate; Homocysteine; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Vitamin B Complex | 2016 |
Elevated Homocysteine Concentrations Decrease the Antihypertensive Effect of Angiotensin-Converting Enzyme Inhibitors in Hypertensive Patients.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biomarkers; Blood Pressure; China; Double-Blind Method; Enalapril; Female; Folic Acid; Homocysteine; Humans; Hypertension; Male; Middle Aged; Time Factors; Treatment Outcome; Up-Regulation | 2017 |
Homocysteine and Stroke Risk: Modifying Effect of Methylenetetrahydrofolate Reductase C677T Polymorphism and Folic Acid Intervention.
Topics: Aged; Antihypertensive Agents; China; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Folic Acid; Follow-Up Studies; Genotype; Homocysteine; Humans; Hypertension; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Stroke; Treatment Outcome; Vitamin B Complex | 2017 |
Association between percent decline in serum total homocysteine and risk of first stroke.
Topics: Aged; Antihypertensive Agents; China; Drug Therapy, Combination; Enalapril; Female; Folic Acid; Homocysteine; Humans; Hypertension; Male; Middle Aged; Risk; Stroke; Vitamin B Complex | 2017 |
Plasma retinol and the risk of first stroke in hypertensive adults: a nested case-control study.
Topics: Aged; Antihypertensive Agents; Brain Ischemia; Case-Control Studies; China; Double-Blind Method; Enalapril; Female; Folic Acid; Hemorrhage; Homocysteine; Humans; Hypertension; Male; Middle Aged; Odds Ratio; Primary Prevention; Risk Factors; Stroke; Vitamin A; Vitamin A Deficiency | 2019 |
2 other study(ies) available for homocysteine and enalapril
| Article | Year |
|---|---|
The intervention of enalapril maleate and folic acid tablet on the expressions of the GRP78 and CHOP and vascular remodeling in the vascular smooth muscle cells of H-hypertensive rats with homocysteine.
Topics: Animals; Enalapril; Folic Acid; Gene Expression; Heat-Shock Proteins; Homocysteine; Hypertension; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Rats; Rats, Sprague-Dawley; Transcription Factor CHOP; Vascular Remodeling | 2018 |
Medical foods for lowering homocysteine in hypertensive patients.
Topics: Blood Pressure; Enalapril; Homocysteine; Humans; Hypertension | 2023 |